DossierENTITY

cancer portfolio

Coverage of cancer portfolio in the Nexus archive.

Earliest in view: Jun 9 · 07:37 UTCMost recent: Jun 9 · 07:37 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJun 9 · 07:37 UTCMARKETWATCH
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
GSK, a U.K. pharmaceutical company, announced a $10.6 billion acquisition of Nuvalent, a U.S.-listed biotech firm, marking its largest purchase in eight years to strengthen its cancer portfolio.